Expressed full-length von Willebrand factor containing missense mutations linked to type IIB von Willebrand disease shows enhanced binding to platelets
Authors:
Open Access
- 15 April 1992
- journal article
- Published by American Society of Hematology in Blood
- Vol. 79 (8) , 2048-2055
Abstract
Von Willebrand disease (vWD) variant type IIB is an inherited bleeding disorder resulting from the spontaneous binding of defective von Willebrand factor (vWF) to platelets in vivo. To identify the molecular basis for type IIB vWD, we used reverse transcription and the polymerase chain reaction to examine the nucleotide sequence of the platelet glycoprotein (GP) Ib-binding domain encoded by the vWF messenger RNA in an affected family, and in an unrelated affected individual. We identified two different missense mutations linked with expression of type IIB vWD. These mutations, which lead to Pro574---- Leu and Val553----Met substitutions, respectively, were each introduced into the full-length vWF expression vector pvW198, and both wild-type (wt) and mutant vWF were transiently expressed in COS-7 cells. Binding assays showed that both mutant proteins showed significant non- ristocetin-dependent spontaneous binding to platelets, and that complete binding was induced by low concentrations of ristocetin that failed to induce platelet binding by wt vWF. The vWF/platelet interaction was inhibited by the anti-vWF monoclonal antibody (MoAb) AvW3, and the anti-GPIb MoAb AP1, which both block vWF binding to platelets. These results show that the identified missense mutations are the likely basis for the expression of type IIB vWD in these affected individuals.Keywords
This publication has 13 references indexed in Scilit:
- The Rapid Differentiation of Type IIb von Willebrand's Disease from Platelet-Type (Pseudo-) von Willebrand's Disease by the “Neutral” Monoclonal Antibody Binding AssayAmerican Journal of Clinical Pathology, 1991
- Dimeric ristocetin flocculates proteins, binds to platelets, and mediates von Willebrand factor-dependent agglutination of plateletsJournal of Biological Chemistry, 1991
- Identification of a point mutation in type IIB von Willebrand disease illustrating the regulation of von Willebrand factor affinity for the platelet membrane glycoprotein Ib-IX receptor.Proceedings of the National Academy of Sciences, 1991
- Cross-linking of a monomeric 39/34-kDa dispase fragment of von Willebrand factor (Leu-480/Val-481-Gly-718) to the N-terminal region of the .alpha.-chain of membrane glycoprotein Ib on intact platelets with bis(sulfosuccinimidyl) suberateBiochemistry, 1989
- Structure of the von Willebrand factor domain interacting with glycoprotein Ib.Journal of Biological Chemistry, 1988
- Identification of disulfide-bridged substructures within human von Willebrand factorBiochemistry, 1987
- A heparin-binding domain of human von Willebrand factor. Characterization and localization to a tryptic fragment extending from amino acid residue Val-449 to Lys-728.Journal of Biological Chemistry, 1987
- Localization of binding sites within human von Willebrand factor for monomeric type III collagenBiochemistry, 1986
- Full‐length von Willebrand factor (vWF) cDNA encodes a highly repetitive protein considerably larger than the mature vWF subunit.The EMBO Journal, 1986
- von Willebrand factor. A reduced and alkylated 52/48-kDa fragment beginning at amino acid residue 449 contains the domain interacting with platelet glycoprotein Ib.Journal of Biological Chemistry, 1986